{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:40:47Z","timestamp":1767854447848,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,1,15]],"date-time":"2008-01-15T00:00:00Z","timestamp":1200355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1245\/s10434-007-9717-9","type":"journal-article","created":{"date-parts":[[2008,1,14]],"date-time":"2008-01-14T14:56:00Z","timestamp":1200322560000},"page":"1476-1484","source":"Crossref","is-referenced-by-count":81,"title":["Prognosis and Determinants of Outcome Following Locoregional or Distant Recurrence in Patients with Cutaneous Melanoma"],"prefix":"10.1245","volume":"15","author":[{"given":"Anne Brecht","family":"Francken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil A.","family":"Accortt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen M.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Wiener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seng-jaw","family":"Soong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald J.","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,1,15]]},"reference":[{"key":"9717_CR1","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S1470-2045(03)01280-4","volume":"4","author":"TK Eigentler","year":"2003","unstructured":"Eigentler TK, Caroli UM, Radny P, et\u00a0al. Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials. Lancet Oncol 2003;4:748\u201359","journal-title":"Lancet Oncol"},{"key":"9717_CR2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/archsurg.1991.01410300045006","volume":"126","author":"JS Markowitz","year":"1991","unstructured":"Markowitz JS, Cosimi LA, Carey RW, et\u00a0al. Prognosis after initial recurrence of cutaneous melanoma. Arch Surg 1991;126:703\u20137","journal-title":"Arch Surg"},{"key":"9717_CR3","first-page":"262","volume":"172","author":"DF Roses","year":"1991","unstructured":"Roses DF, Karp NS, Oratz R, et\u00a0al. Survival with regional and distant metastases from cutaneous malignant melanoma. Surg Gynecol Obstet 1991;172:262\u20138","journal-title":"Surg Gynecol Obstet"},{"key":"9717_CR4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1096-9098(199804)67:4<228::AID-JSO4>3.0.CO;2-A","volume":"67","author":"SJ Soong","year":"1998","unstructured":"Soong SJ, Harrison RA, McCarthy WH, et\u00a0al. Factors affecting survival following local, regional, or distant recurrence from localized melanoma. J Surg Oncol 1998;67:228\u201333","journal-title":"J Surg Oncol"},{"key":"9717_CR5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/028418699431122","volume":"38","author":"G Cohn-Cedermark","year":"1999","unstructured":"Cohn-Cedermark G, Mansson-Brahme E, Rutqvist LE, et\u00a0al. Metastatic patterns, clinical outcome, and malignant phenotype in malignant cutaneous melanoma. Acta Oncol 1999;38:549\u201357","journal-title":"Acta Oncol"},{"key":"9717_CR6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-2133.2002.04867.x","volume":"147","author":"F Meier","year":"2002","unstructured":"Meier F, Will S, Ellwanger U, et\u00a0al. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol 2002;147:62\u201370","journal-title":"Br J Dermatol"},{"key":"9717_CR7","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2345::AID-CNCR8>3.0.CO;2-K","volume":"79","author":"CU Brand","year":"1997","unstructured":"Brand CU, Ellwanger U, Stroebel W, et\u00a0al. Prolonged survival of 2\u00a0years or longer for patients with disseminated melanoma. An analysis of related prognostic factors. Cancer 1997;79:2345\u201353","journal-title":"Cancer"},{"key":"9717_CR8","first-page":"295","volume":"115","author":"CP Karakousis","year":"1994","unstructured":"Karakousis CP, Velez A, Driscoll DL, et\u00a0al. Metastasectomy in malignant melanoma. Surgery 1994;115:295\u2013302","journal-title":"Surgery"},{"key":"9717_CR9","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0190-9622(96)90017-1","volume":"34","author":"RA Buzzell","year":"1996","unstructured":"Buzzell RA, Zitelli JA. Favorable prognostic factors in recurrent and metastatic melanoma. J Am Acad Dermatol 1996;34:798\u2013803","journal-title":"J Am Acad Dermatol"},{"key":"9717_CR10","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/archsurg.1992.01420110045011","volume":"127","author":"NJ Crowley","year":"1992","unstructured":"Crowley NJ, Seigler HF. Relationship between disease-free interval and survival in patients with recurrent melanoma. Arch Surg 1992;127:1303\u20138","journal-title":"Arch Surg"},{"key":"9717_CR11","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/archsurg.139.9.961","volume":"139","author":"R Essner","year":"2004","unstructured":"Essner R, Lee JH, Wanek LA, et\u00a0al. Contemporary surgical treatment of advanced-stage melanoma. Arch Surg 2004;139:961\u20136","journal-title":"Arch Surg"},{"key":"9717_CR12","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Buzaid AC, Soong SJ, et\u00a0al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19:3635\u201348","journal-title":"J Clin Oncol"},{"key":"9717_CR13","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Soong SJ, Gershenwald JE, et\u00a0al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622\u201334","journal-title":"J Clin Oncol"},{"key":"9717_CR14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1245\/ASO.2004.07.014","volume":"11","author":"AB Francken","year":"2004","unstructured":"Francken AB, Shaw HM, Thompson JF, et\u00a0al. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up. Ann Surg Oncol 2004;11:426\u201333","journal-title":"Ann Surg Oncol"},{"key":"9717_CR15","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/cncr.11196","volume":"97","author":"MF Azzola","year":"2003","unstructured":"Azzola MF, Shaw HM, Thompson JF, et\u00a0al. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center. Cancer 2003;97:1488\u201398","journal-title":"Cancer"},{"key":"9717_CR16","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/(SICI)1097-0142(19970915)80:6<1052::AID-CNCR7>3.0.CO;2-B","volume":"80","author":"MM Mooney","year":"1997","unstructured":"Mooney MM, Mettlin C, Michalek AM, et\u00a0al. Life-long screening of patients with intermediate-thickness cutaneous melanoma for asymptomatic pulmonary recurrences: a cost-effectiveness analysis. Cancer 1997;80:1052\u201364","journal-title":"Cancer"},{"key":"9717_CR17","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1470-2045(06)70938-X","volume":"7","author":"DW Ollila","year":"2006","unstructured":"Ollila DW. Complete metastasectomy in patients with stage IV metastatic melanoma. Lancet Oncol 2006;7:919\u201324","journal-title":"Lancet Oncol"},{"key":"9717_CR18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jtcvs.2006.08.065","volume":"133","author":"RP Petersen","year":"2007","unstructured":"Petersen RP, Hanish SI, Haney JC, et\u00a0al. Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. J Thorac Cardiovasc Surg 2007;133:104\u201310","journal-title":"J Thorac Cardiovasc Surg"},{"key":"9717_CR19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10434-001-0109-2","volume":"8","author":"I Pidhorecky","year":"2001","unstructured":"Pidhorecky I, Lee RJ, Proulx G, et\u00a0al. Risk factors for nodal recurrence after lymphadenectomy for melanoma. Ann Surg Oncol 2001;8:109\u201315","journal-title":"Ann Surg Oncol"},{"key":"9717_CR20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00008390-200010000-00011","volume":"10","author":"L Kretschmer","year":"2000","unstructured":"Kretschmer L, Preusser KP, Marsch WC, et\u00a0al. Prognostic factors of overall survival in patients with delayed lymph node dissection for cutaneous malignant melanoma. Melanoma Res 2000;10:483\u20139","journal-title":"Melanoma Res"},{"key":"9717_CR21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00008390-200208000-00008","volume":"12","author":"MM Konstadoulakis","year":"2002","unstructured":"Konstadoulakis MM, Messaris E, Zografos G, et\u00a0al. Common prognostic factors for stage III melanoma patients and for stage I and II melanoma patients with recurrence to their regional lymph nodes. Melanoma Res 2002;12:357\u201364","journal-title":"Melanoma Res"},{"key":"9717_CR22","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1288\/00005537-198906000-00004","volume":"99","author":"DJ Hoyt","year":"1989","unstructured":"Hoyt DJ, Fisher SR. Survival following recurrent malignant melanoma of the head and neck. Laryngoscope 1989;99:586\u20139","journal-title":"Laryngoscope"},{"key":"9717_CR23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/01.sla.0000251746.02764.fc","volume":"245","author":"A Sanki","year":"2007","unstructured":"Sanki A, Kam PC, Thompson JF. Long-term results of hyperthermic, isolated limb perfusion for melanoma: a reflection of tumor biology. Ann Surg 2007;245:591\u20136","journal-title":"Ann Surg"},{"key":"9717_CR24","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/BF02305762","volume":"3","author":"CP Karakousis","year":"1996","unstructured":"Karakousis CP, Balch CM, Urist MM, et\u00a0al. Local recurrence in malignant melanoma: long-term results of the multi-institutional randomized surgical trial. Ann Surg Oncol 1996;3:446\u201352","journal-title":"Ann Surg Oncol"},{"key":"9717_CR25","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1001\/archsurg.1992.01420120046008","volume":"127","author":"MA Gadd","year":"1992","unstructured":"Gadd MA, Coit DG. Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma. Arch Surg 1992;127:1412\u20136","journal-title":"Arch Surg"},{"key":"9717_CR26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10434-000-0087-9","volume":"7","author":"CM Balch","year":"2000","unstructured":"Balch CM, Soong S, Ross MI, et\u00a0al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0\u00a0mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 2000;7:87\u201397","journal-title":"Ann Surg Oncol"},{"key":"9717_CR27","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(97)08260-3","volume":"351","author":"N Cascinelli","year":"1998","unstructured":"Cascinelli N, Morabito A, Santinami M, et\u00a0al. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 1998;351:793\u20136","journal-title":"Lancet"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-007-9717-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-007-9717-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-007-9717-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T06:49:51Z","timestamp":1708498191000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-007-9717-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,15]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["9717"],"URL":"https:\/\/doi.org\/10.1245\/s10434-007-9717-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,15]]}}}